References
- Volkow N. Alone in the dark: prescription drug abuse. The Enterprise; 2015 [accessed 2018 July 16]. http://www.enterprisenews.com/article/20150220/news/150229946.
- Planalp C, Hest R, Lahr M. The opioid epidemic: national trends in opioid-related overdose deaths from 2000 to 2017; 2019 [accessed 2019 December 10]. https://www.shadac.org/sites/default/files/publications/2019%20NATIONAL%20opioid%20brief%20FINAL%20VERSION.pdf.
- Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068, NSDUH Series H-54). Rockville (MD): Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2019. https://www.samhsa.gov/data/.
- Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths—United States, 2013–2017. Morb Mortal Wkly Rep. 2019;67:1419.
- Centers for Disease Control and Prevention. 2019 Annual Surveillance Report of Drug-Related Risks and Outcomes — United States Surveillance Special Report. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; [ accessed 2019 Nov 1]. https://www.cdc.gov/drugoverdose/pdf/pubs/2019-cdc-drug-surveillance-report.pdf.
- Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125:8–18. doi:10.1016/j.drugalcdep.2012.07.004.
- US Food and Drug Administration. FDA drug safety communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning; 2016 [accessed 2018 July 16]. www.fda.gov/Drugs/DrugSafety/ucm518473.htm.
- National Institute on Drug Abuse. Benzodiazepines and opioids; 2018 [accessed 2018 July 16]. https://www.drugabuse.gov/drugs-abuse/opioids/benzodiazepines-opioids.
- Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ. 2017;356:j760. doi:10.1136/bmj.j760.
- Hernandez I, He M, Brooks MM, Zhang Y. Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in medicare part D beneficiaries. JAMA Netw Open. 2018;1:e180919–e. doi:10.1001/jamanetworkopen.2018.0919.
- Centers for Medicare and Medicaid Services. Reduce risk of opioid overdose deaths by avoiding and reducing co-prescribing benzodiazepines; 2019 Jul 1; [accessed 2019 December 10]. https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/SE19011.pdf.
- Agarwal SD, Landon BE. Patterns in outpatient benzodiazepine prescribing in the United States. JAMA Netw Open. 2019;2:e187399–e. doi:10.1001/jamanetworkopen.2018.7399.
- Wood D. Drug diversion. Aust Prescr. 2015;38:164–66. doi:10.18773/austprescr.2015.058.
- Hulme S, Bright D, Nielsen S. The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis. Drug Alcohol Depend. 2018;186:242–56. doi:10.1016/j.drugalcdep.2018.02.010.
- McCabe SE, Cranford JA, Boyd CJ, Teter CJ. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict Behav. 2007;32:562–75. doi:10.1016/j.addbeh.2006.05.022.
- Simoni-Wastila L. The use of abusable prescription drugs: the role of gender. J Womens Health Gend Based Med. 2000;9:289–97. doi:10.1089/152460900318470.
- Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry. 2015;72:136–42. doi:10.1001/jamapsychiatry.2014.1763.
- White C, Ready J, Katz CM. Examining how prescription drugs are illegally obtained: social and ecological predictors. J Drug Issues. 2015;46:4–23.
- Cicero TJ, Kurtz SP, Surratt HL, Ibanez GE, Ellis MS, Levi-Minzi MA, Inciardi JA. Multiple determinants of specific modes of prescription opioid diversion. J Drug Issues. 2011;41:283–304.
- Hwang CS, Kang EM, Kornegay CJ, Staffa JA, Jones CM, McAninch JK. Trends in the concomitant prescribing of opioids and benzodiazepines, 2002–2014. Am J Prev Med. 2016;51:151–60. doi:10.1016/j.amepre.2016.02.014.
- Centers for Medicare and Medicaid Services. Concurrent use of opioids and benzodiazepines in a Medicare Part D population. [ accessed 2016 May 12]. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Concurrent-Use-of-Opioids-and-Benzodiazepines-in-a-Medicare-Part-D-Population-CY-2015.pdf.
- Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350:h2698. doi:10.1136/bmj.h2698.
- McClure FL, Niles JK, Kaufman HW, Gudin J. Concurrent use of opioids and benzodiazepines: evaluation of prescription drug monitoring by a United States laboratory. J Addict Med. 2017;11:420–26. doi:10.1097/ADM.0000000000000354.
- Boggis JS, Feder K. Trends in and correlates of tranquilizer misuse among adults who misuse opioids in the United States, 2002–2014. Drug Alcohol Depend. 2019. doi:10.1016/j.drugalcdep.2019.01.014.
- Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016;65:1–49. doi:10.15585/mmwr.rr6501e1.
- Zhu W, Chernew ME, Sherry TB, Maestas N. Initial opioid prescriptions among U.S. commercially insured patients, 2012–2017. N Engl J Med. 2019;380:1043–52. doi:10.1056/NEJMsa1807069.
- Schieber LZ, Guy GP Jr., Seth P, Young R, Mattson CL, Mikosz CA, Schieber RA. Trends and patterns of geographic variation in opioid prescribing practices by state, United States, 2006–2017. JAMA Netw Open. 2019;2:e190665.
- Ladapo JA, Larochelle MR, Chen A, Villalon MM, Vassar S, Huang DYC, Mafi JN. Physician prescribing of opioids to patients at increased risk of overdose from benzodiazepine use in the United States. JAMA Psychiatry. 2018;75:623–30.
- Cicero TJ, Kasper ZA, Ellis MS. Increased use of heroin as an initiating opioid of abuse: further considerations and policy implications. Addict Behav. 2018;87:267–71. doi:10.1016/j.addbeh.2018.05.030.
- Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015;373:1789–90. doi:10.1056/NEJMc1505541.
- Lipari RN, Williams M, Van Horn SL Why Do Adults Misuse Prescription Drugs? The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013. 1–10 p.
- Kennedy-Hendricks A, Gielen A, McDonald E, McGinty EE, Shields W, Barry CL. Medication sharing, storage, and disposal practices for opioid medications among US adultssharing, storage, and disposal practices for opioidsletters. JAMA Intern Med. 2016;176:1027–29. doi:10.1001/jamainternmed.2016.2543.
- Nouri PK. Distribution and community reception of medication disposal pouches compared with distribution of unintentional overdose-related deaths in montgomery county. Dayton (OH): Wright State University; 2018.
- World Health Organization. Substandard and falsified medical product. [ accessed 2018 Jan 31]. https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products.
- Johnston A, Holt DW. Substandard drugs: a potential crisis for public health. Br J Clin Pharmacol. 2014;78:218–43. doi:10.1111/bcp.12298.
- Liu Y, Williamson V, Setlow B, Cottler LB, Knackstedt LA. The importance of considering polysubstance use: lessons from cocaine research. Drug Alcohol Depend. 2018;192:16–28. doi:10.1016/j.drugalcdep.2018.07.025.